Cryomarex Rispens

Χώρα: Ιρλανδία

Γλώσσα: Αγγλικά

Πηγή: HPRA (Health Products Regulatory Authority)

Δραστική ουσία:

Marek disease virus (rispens strain)

Διαθέσιμο από:

Merial Animal Health Limited

Φαρμακολογική κατηγορία (ATC):

QI01AD03

INN (Διεθνής Όνομα):

Marek disease virus (rispens strain)

Δοσολογία:

.

Φαρμακοτεχνική μορφή:

Suspension for injection

Τρόπος διάθεσης:

POM: Prescription Only Medicine as defined in relevant national legislation

Θεραπευτική ομάδα:

Chickens

Θεραπευτική περιοχή:

avian herpes virus (marek's disease)

Θεραπευτικές ενδείξεις:

Immunological - Live Vaccine

Καθεστώς αδειοδότησης:

Authorised

Ημερομηνία της άδειας:

2006-12-15

Αρχείο Π.Χ.Π.

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Cryomarex Rispens
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each dose contains:
ACTIVE INGREDIENT:
Marek’s disease virus, Rispens strain, attenuated, at least
1000 PFU
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Suspension for injection
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Chickens.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For active immunisation of chickens to reduce mortality, clinical
signs and lesions linked to Marek’s disease. The onset
of protection is from 5 days following vaccination. While the duration
of immunity has not been investigated under
laboratory conditions, a single vaccine dose is considered sufficient
to provide protection throughout the risk period.
4.3 CONTRAINDICATIONS
None.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_3_
_/_
_0_
_1_
_/_
_2_
_0_
_1_
_4_
_C_
_R_
_N_
_ _
_7_
_0_
_1_
_4_
_9_
_0_
_7_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Only healthy birds should be vaccinated.
Rispens strain virus is excreted by vaccinates and may spread to
in-contact birds. Safety and reversion to virulence
trials have shown that the spread to in-contact birds can be
considered as safe.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
The operator should be aware of the general